A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai(The Francis Crick Institute), Igor Astsaturov(Fox Chase Cancer Center), Edna Cukierman(Fox Chase Cancer Center), David G. DeNardo(Washington University in St. Louis), Mikala Egeblad(Cold Spring Harbor Laboratory), Ronald M. Evans(Salk Institute for Biological Studies), Douglas T. Fearon(Cornell University), Florian R. Greten(Goethe University Frankfurt), Sunil R. Hingorani(Fred Hutch Cancer Center), Tony Hunter(Salk Institute for Biological Studies), Richard O. Hynes(Massachusetts Institute of Technology), Rakesh K. Jain(Harvard University), Tobias Janowitz(Northwell Health), Claus Jørgensen(University of Manchester), Alec C. Kimmelman(University Medical Center), Mikhail G. Kolonin(Brown Foundation), Robert G. Maki(Northwell Health), Scott Powers(Stony Brook University), Ellen Puré(University of Pennsylvania), Daniel C. Ramirez(Northwell Health), Ruth Scherz‐Shouval(Weizmann Institute of Science), Mara H. Sherman(Oregon Health & Science University), Sheila A. Stewart(Washington University in St. Louis), Thea D. Tlsty(University of California, San Francisco), David A. Tuveson(Cold Spring Harbor Laboratory), Fiona M. Watt(Guy's Hospital), Valerie M. Weaver(University of California, San Francisco), Ashani T. Weeraratna(Johns Hopkins University), Zena Werb(University of California, San Francisco)
Nature reviews. Cancer
January 24, 2020
Cited by 3,725Open Access
Full Text

Abstract

Cancer-associated fibroblasts (CAFs) are a key component of the tumour microenvironment with diverse functions, including matrix deposition and remodelling, extensive reciprocal signalling interactions with cancer cells and crosstalk with infiltrating leukocytes. As such, they are a potential target for optimizing therapeutic strategies against cancer. However, many challenges are present in ongoing attempts to modulate CAFs for therapeutic benefit. These include limitations in our understanding of the origin of CAFs and heterogeneity in CAF function, with it being desirable to retain some antitumorigenic functions. On the basis of a meeting of experts in the field of CAF biology, we summarize in this Consensus Statement our current knowledge and present a framework for advancing our understanding of this critical cell type within the tumour microenvironment.


Related Papers

No related papers found

Powered by citation graph analysis